|
GPATCH8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.868400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.925000E-01 |
| Normal-vs-Stage2 |
1.792380E-01 |
| Normal-vs-Stage3 |
3.959800E-01 |
| Normal-vs-Stage4 |
6.146800E-01 |
| Stage1-vs-Stage2 |
2.201200E-01 |
| Stage1-vs-Stage3 |
6.513000E-01 |
| Stage1-vs-Stage4 |
7.917200E-01 |
| Stage2-vs-Stage3 |
5.137800E-01 |
| Stage2-vs-Stage4 |
6.174200E-01 |
| Stage3-vs-Stage4 |
9.789800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.167800E-01 |
| Normal-vs-AfricanAmerican |
4.277000E-01 |
| Normal-vs-Asian |
5.023400E-01 |
| Caucasian-vs-AfricanAmerican |
7.231800E-01 |
| Caucasian-vs-Asian |
8.198000E-01 |
| AfricanAmerican-vs-Asian |
9.463400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.568200E-01 |
| Normal-vs-Female |
1.041820E-03 |
| Male-vs-Female |
2.085000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.105000E-01 |
| Normal-vs-Extreme_Weight |
8.870000E-01 |
| Normal-vs-Obese |
2.646400E-02 |
| Normal-vs-Extreme_Obese |
5.574800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.795600E-01 |
| Normal_Weight-vs-Obese |
1.721380E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.510200E-01 |
| Extreme_Weight-vs-Obese |
3.235600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.826400E-01 |
| Obese-vs-Extreme_Obese |
1.479440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.012370E-02 |
| Normal-vs-Age(41-60Yrs) |
4.422800E-03 |
| Normal-vs-Age(61-80Yrs) |
9.751800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.444000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.494200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.423000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.796900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.558400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.006200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.070800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.436500E-02 |
| Normal-VS-Type2 PRCC |
1.138820E-01 |
| Normal-VS-KIRP CIMP |
4.138100E-02 |
| Normal-VS-Unclassified PRCC |
9.184500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.796300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.795800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.901800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.990140E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.277520E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.052200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.403400E-01 |
| Normal-vs-N1 |
8.126000E-02 |
| Normal-vs-N2 |
4.488200E-01 |
| N0-vs-N1 |
3.827600E-02 |
| N0-vs-N2 |
1.090380E-01 |
| N1-vs-N2 |
8.957200E-01 |
|
|
